Clal Biotechnology reported ILS38.43M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 2.43B 963M Mar/2026
Bio Path USD 1000K 0 Mar/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Cara Therapeutics USD 30M 336M Mar/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
Immunic USD 64M 23M Dec/2025
RedHill Biopharma USD 1000K 4M Sep/2026